V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260019257 | 260009875 | 1.88 | 54 | Palliative (P) | 2018-10-23 | 2018-11-02 | Gemcitabine + Oxaliplatin | N | N | 260030004 | POMB |
| 260019258 | 260009926 | null | 64 | Adjuvant (A) | null | 2019-02-06 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260006047 | PACLITAXEL |
| 260019259 | 260009962 | 1.66 | 56.6 | Disease modification (D) | 2016-07-13 | 2016-09-04 | TRASTUZUMAB | N | N | 260007890 | BLEOMYCIN + VINCRISTINE |
| 260019260 | 260010022 | 1.69 | 83 | Adjuvant (A) | 2017-10-03 | 2017-10-03 | Escalated BEACOPP | 2 | N | 260009510 | CARBO + THIOTEPA + TOPOTECAN |
| 260019261 | 260018825 | 1.72 | 88.8 | Disease modification (D) | 2016-01-25 | 2016-01-26 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | 260011894 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260019262 | 260010103 | 1.78 | 89 | Curative (C) | 2018-04-04 | 2018-04-04 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 2 | N | 260012314 | IFOSFAMIDE + PACLITAXEL |
| 260019263 | 260014795 | 1.69 | 97 | Disease modification (D) | 2016-09-18 | 2016-09-19 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL | 2 | N | 260014167 | IFOSFAMIDE + PACLITAXEL |
| 260019264 | 260014814 | null | 65 | null | 2017-03-17 | 2017-06-10 | DHAP | N | N | 260019645 | CISPLATIN + GEMCITABINE |
| 260019265 | 260010186 | 1.79 | 65.4 | null | 2018-06-12 | 2018-06-12 | BLEOMYCIN | 2 | N | 260021633 | GEMCITABINE + OXALIPLATIN |
| 260019266 | 260010201 | 1.75 | 106 | Palliative (P) | 2018-03-19 | 2018-03-19 | VIP | 2 | N | 260028027 | CARBOPLATIN + ETOPOSIDE |
| 260019267 | 260014829 | 1.76 | null | Curative (C) | 2017-11-05 | 2017-11-10 | CISPLATIN + EPIRUBICIN | null | Y | 260029516 | IFOSFAMIDE + PACLITAXEL |
| 260019268 | 260010218 | 1.65 | 65 | Curative (C) | 2017-05-02 | 2017-05-18 | Cytarabine HD + Methotrexate HD | 2 | N | 260006709 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260019269 | 260010226 | null | 46.2 | Palliative (P) | 2017-11-08 | 2018-06-27 | CVP | N | N | 260007252 | METHOTREXATE |
| 260019270 | 260012603 | null | null | Palliative (P) | 2017-08-08 | 2017-08-08 | Rituximab | 02 | N | 260015694 | RITUXIMAB |
| 260019271 | 260006597 | 1.7 | null | Palliative (P) | 2015-07-18 | 2015-07-18 | Rituximab (Maintenance) | 02 | N | 260016181 | RITUXIMAB |
| 260019272 | 260006630 | null | 56.5 | Palliative (P) | 2015-04-16 | 2016-07-26 | Rituximab (Maintenance) | N | N | 260016457 | RITUXIMAB |
| 260019273 | 260006921 | 1.76 | 95.2 | Disease modification (D) | 2018-08-20 | 2018-09-20 | Rituximab | 02 | N | 260019353 | RITUXIMAB |
| 260019274 | 260006956 | 0 | 75 | Disease modification (D) | 2019-12-22 | 2020-07-29 | Rituximab (Maintenance) | 02 | N | 260019486 | RITUXIMAB |
| 260019275 | 260006976 | 1.8 | 69.6 | Palliative (P) | 2018-03-14 | 2018-03-23 | Rituximab (Maintenance) | 02 | N | 260019558 | RITUXIMAB |
| 260019276 | 260007122 | 1.73 | 89 | Palliative (P) | 2018-02-19 | 2018-08-13 | Rituximab | N | N | 260020175 | RITUXIMAB |
| 260019277 | 260007419 | 0 | 69.7 | Disease modification (D) | 2018-09-13 | 2019-03-21 | Rituximab | N | N | 260021811 | RITUXIMAB |
| 260019278 | 260007441 | null | 91.8 | Curative (C) | 2016-12-05 | 2018-04-08 | Rituximab | null | null | 260021909 | RITUXIMAB |
| 260019279 | 260013352 | null | 77 | Curative (C) | 2016-11-25 | 2016-11-29 | Rituximab (Maintenance) | N | null | 260022340 | RITUXIMAB |
| 260019280 | 260013647 | 1.9 | 79.2 | Disease modification (D) | 2018-12-28 | 2019-07-23 | Rituximab | N | N | 260024390 | RITUXIMAB |
| 260019281 | 260013775 | null | 83.8 | Palliative (P) | 2020-01-22 | 2021-01-11 | Rituximab | N | N | 260025104 | RITUXIMAB |
| 260019282 | 260008151 | null | 132 | Disease modification (D) | 2017-06-21 | 2017-06-21 | Rituximab | 2 | N | 260025353 | RITUXIMAB |
| 260019283 | 260008169 | 1.76 | 80 | Palliative (P) | 2018-08-08 | 2019-10-18 | Rituximab (Maintenance) | N | N | 260025413 | RITUXIMAB |
| 260019284 | 260008319 | 1.55 | null | Disease modification (D) | null | 2019-08-30 | Rituximab (Maintenance) | N | N | 260025735 | RITUXIMAB |
| 260019285 | 260008338 | 1.78 | 87.7 | Disease modification (D) | 2017-05-29 | 2018-04-17 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260025762 | RITUXIMAB |
| 260019286 | 260008416 | 1.73 | 80 | Palliative (P) | 2018-10-20 | 2018-10-22 | Rituximab | 2 | N | 260025936 | RITUXIMAB |
| 260019288 | 260008546 | 1.78 | 103.5 | Disease modification (D) | 2018-07-02 | 2018-07-09 | Rituximab (Maintenance) | 2 | Y | 260026154 | RITUXIMAB |
| 260019289 | 260008557 | 1.73 | null | Palliative (P) | 2017-12-09 | 2018-05-29 | Rituximab | N | N | 260026185 | RITUXIMAB |
| 260019290 | 260014072 | 1.66 | null | Curative (C) | 2017-07-31 | 2017-08-02 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260026246 | RITUXIMAB |
| 260019291 | 260008623 | null | 70.6 | null | 2015-02-16 | 2015-02-23 | Rituximab (Maintenance) | null | null | 260026293 | RITUXIMAB |
| 260019292 | 260008631 | 1.8 | 91.7 | Not known (9) | 2018-10-15 | 2018-10-17 | Rituximab | N | N | 260026309 | RITUXIMAB |
| 260019293 | 260014122 | 0 | 75.2 | Palliative (P) | 2017-10-31 | 2018-05-19 | Rituximab | N | N | 260026416 | RITUXIMAB |
| 260019294 | 260014143 | null | 81.25 | Palliative (P) | null | 2018-05-30 | Rituximab | N | N | 260026470 | RITUXIMAB |
| 260019295 | 260008728 | null | 80.2 | Curative (C) | 2014-03-04 | 2014-04-07 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260026484 | RITUXIMAB |
| 260019296 | 260008739 | 1.78 | 102.1 | Palliative (P) | 2014-10-26 | 2014-10-27 | Rituximab (Maintenance) | 2 | N | 260026494 | RITUXIMAB |
| 260019297 | 260008763 | null | 83.5 | Disease modification (D) | 2018-10-20 | 2019-03-31 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260026524 | RITUXIMAB |
| 260019298 | 260008764 | null | null | Not known (9) | 2014-06-16 | 2014-06-18 | Rituximab | 02 | N | 260026526 | RITUXIMAB |
| 260019299 | 260008773 | 1.77 | 65 | Palliative (P) | 2016-06-22 | 2017-05-03 | Rituximab (Maintenance) | N | N | 260026547 | RITUXIMAB |
| 260019300 | 260008787 | 1.73 | 63.5 | Curative (C) | 2015-01-28 | 2015-01-28 | Rituximab (Maintenance) | N | null | 260026570 | RITUXIMAB |
| 260019301 | 260008793 | null | 82.9 | Palliative (P) | 2016-12-08 | 2016-12-16 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | null | 260026584 | RITUXIMAB |
| 260019302 | 260008801 | null | 80 | Disease modification (D) | 2017-08-25 | 2017-08-25 | Rituximab | 02 | N | 260026596 | RITUXIMAB |
| 260019303 | 260008806 | 1.83 | 69.8 | Curative (C) | 2017-05-11 | 2017-07-05 | Rituximab (Maintenance) | 02 | N | 260026609 | RITUXIMAB |
| 260019304 | 260008828 | 2 | 89.5 | Curative (C) | 2016-03-12 | 2016-06-21 | BEP 3 day | 02 | N | 260026664 | BEP |
| 260019305 | 260008840 | 1.78 | 90 | Curative (C) | 2015-10-10 | 2015-11-08 | BEP 3 day | null | N | 260026674 | BEP |
| 260019306 | 260008844 | 1.71 | 90 | Curative (C) | 2015-08-20 | 2015-09-10 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260026676 | BENDAMUSTINE + RITUXIMAB |
| 260019307 | 260008850 | 1.85 | 86 | Palliative (P) | 2017-06-17 | 2017-06-17 | CVP R | N | N | 260026683 | CVP R |